Medical Devices

Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ

Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, announces that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. (“KARL STORZ”), a wholly owned direct subsidiary of KARL STORZ SE & Co. KG, an independent,

Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ Read More »

Johnson & Johnson Completes Acquisition of Shockwave Medical

Johnson & Johnson (NYSE: JNJ) announces it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech. This transaction further extends Johnson & Johnson MedTech’s leadership in cardiovascular intervention. Shockwave offers the first and only commercially available intravascular

Johnson & Johnson Completes Acquisition of Shockwave Medical Read More »

PitchBook’s Q1 2024 Medtech Report

Medtech VC investment rebounded significantly to $3.3 billion in Q1 as investors piled into high-quality companies despite historically low deal volume, PitchBook’s Q1 2024 Medtech Report explains. The largest deal went to early cancer detection startup Freenome, which raised a $254 million late-stage round led by Roche Venture Fund. Public medtech valuations have stabilized, and

PitchBook’s Q1 2024 Medtech Report Read More »

Surmodics Enters into Definitive Agreement to Be Acquired by GTCR for $43.00 Per Share in Cash

Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, announces that it has entered into a definitive agreement to be acquired by GTCR, a leading private equity firm with a long track record of investment expertise across healthcare and healthcare technology. “With its longstanding, blue chip

Surmodics Enters into Definitive Agreement to Be Acquired by GTCR for $43.00 Per Share in Cash Read More »

Scroll to Top